
Cytosorbents Corporation CTSO
$ 6.41
0.63%
Cytosorbents Corporation DSO Ratio | CTSO
Annual DSO Ratio Cytosorbents Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.2 | 68.6 | 68.8 | 198 | 164 | 147 | 65.4 | 64 | 53.1 | 54.9 | 49.4 | 72.5 | 68.3 | 14.1 | 365 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 365 | 14.1 | 102 |
Quarterly DSO Ratio Cytosorbents Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66 | 75 | 73 | 73.1 | 78.4 | - | 76.6 | 75.3 | 65.1 | - | 68.4 | 60.8 | 54 | - | 27.9 | 24.6 | 47.8 | 41.3 | 51.4 | 40.9 | 43.8 | 39.4 | 44.6 | 48.1 | 50.4 | 54.9 | 66.9 | 65.4 | 73.9 | 59.2 | 62.6 | 62.5 | 57 | 43.3 | 52.6 | 56.4 | 53.3 | 42.4 | 54.2 | 58.9 | 52.5 | 33.6 | 39 | 55.5 | 94.1 | 72.1 | 35 | 51.2 | 54.6 | - | 46.9 | 142 | 62 | - | 7.81 | 56.9 | 79.8 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 142 | 7.81 | 57.2 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Inari Medical
NARI
|
47.6 | - | - | $ 4.23 B | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 101.95 | 0.24 % | $ 177 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 126.0 | 0.06 % | $ 4.38 B | ||
|
Axonics Modulation Technologies
AXNX
|
50.8 | - | - | $ 3.31 B | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 6.06 | 3.59 % | $ 819 M | ||
|
Align Technology
ALGN
|
94.9 | $ 150.82 | 0.07 % | $ 10.9 B | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Sientra
SIEN
|
510 | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
42.8 | - | - | $ 1.07 B | ||
|
Surgalign Holdings
SRGA
|
78.5 | - | -32.98 % | $ 1.68 M | ||
|
ShockWave Medical
SWAV
|
46.5 | - | - | $ 12.3 B | ||
|
ThermoGenesis Holdings
THMO
|
54.4 | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
30.6 | - | 3.55 % | $ 7.96 M | ||
|
Viveve Medical
VIVE
|
37.5 | - | -15.35 % | $ 1.71 M | ||
|
ViewRay
VRAY
|
113 | - | 1.54 % | $ 468 M | ||
|
Natus Medical Incorporated
NTUS
|
79 | - | 1.94 % | $ 1.05 B | ||
|
Acutus Medical
AFIB
|
174 | - | -26.83 % | $ 2.62 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | ||
|
SmileDirectClub
SDC
|
127 | - | -53.45 % | $ 9.71 M | ||
|
Apyx Medical Corporation
APYX
|
111 | $ 2.9 | 0.35 % | $ 119 M | ||
|
Accuray Incorporated
ARAY
|
68.4 | $ 0.25 | 2.96 % | $ 30.7 M | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 10.58 | 19.68 % | $ 1.59 B | ||
|
AxoGen
AXGN
|
40.7 | $ 42.16 | 0.74 % | $ 1.94 B | ||
|
Bio-Rad Laboratories
BIO
|
64.5 | $ 369.32 | 0.15 % | $ 10.1 B | ||
|
Bruker Corporation
BRKR
|
59 | $ 53.43 | 0.19 % | $ 8.11 B | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 42.98 | 0.44 % | $ 63.6 B | ||
|
Cognyte Software Ltd.
CGNT
|
106 | $ 8.02 | 0.91 % | $ 585 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 13.72 | 1.78 % | $ 388 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 46.3 | 0.17 % | $ 1.44 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
48.5 | $ 15.91 | 0.7 % | $ 570 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Electromed
ELMD
|
135 | $ 27.25 | 2.25 % | $ 225 M | ||
|
Establishment Labs Holdings
ESTA
|
123 | $ 70.94 | 0.32 % | $ 2.1 B | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 84.37 | 0.73 % | $ 49.3 B | ||
|
Globus Medical
GMED
|
76.8 | $ 74.19 | 0.86 % | $ 10 B | ||
|
Helius Medical Technologies
HSDT
|
2.12 | $ 2.22 | 3.26 % | $ 48.9 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
61.5 | $ 15.5 | 0.39 % | $ 1.19 B |